Surveillance Versus Bronchoscopy After Airway Stenting

Description

Randomized, pilot study that evaluates surveillance bronchoscopy versus no surveillance for patients that undergo tracheobronchial stenting

Conditions

Bronchial Stents

Talk to us

Study Overview

On this page

Study Details

Study overview

Randomized, pilot study that evaluates surveillance bronchoscopy versus no surveillance for patients that undergo tracheobronchial stenting

Surveillance Versus Prn bronChOscoPy aftEr aIrway stenTing (SCOPE-IT)

Surveillance Versus Bronchoscopy After Airway Stenting

Condition
Bronchial Stents
Intervention / Treatment

-

Contacts and Locations

New York

The Mount Sinai Health System, New York, New York, United States, 10029

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * All adult patients that undergo central airway (trachea, main stem bronchi and bronchus intermedius) stenting.
  • * Inability to obtain informed consent due to cognitive, neurologic or psychiatric impairment.
  • * Lobar or segmental stents alone
  • * Terminally ill patients considered too sick to undergo a follow-up surveillance bronchoscopy
  • * Stent insertion as a trial for excessive central airway collapse (as the duration of these stents is only 1-2 weeks)
  • * Patients with a tracheostomy (as these patients can undergo frequent in-line suctioning that can affect the outcomes being assessed)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Icahn School of Medicine at Mount Sinai,

Udit Chaddha, MBBS, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine

Study Record Dates

2026-03-31